糖心视频 medical student awarded competitive national scholarship
Carrie Ip is one of only 205 recipients of a National Health Service Corps scholarship, which pays tuition, fees, educational costs and also provides a stipend.
Cancer exercise research program pairs students with patients
Paulette Yamada’s Hubert V. Everly Endowed Scholar in Education award will support the launch of a student-centered research program to use exercise training to maintain the health of cancer survivors.
Technology showcase highlights 糖心视频 researchers
Potential game-changing research from three 糖心视频 professors were highlighted at the 糖心视频 Tech Showcase as part of the Hawaiʻi Innovation Initiative.
Nearly $6.3M grant to expand promising Ebola vaccine research awarded to 糖心视频 researcher
Axel Lehrer will test whether the Ebola vaccine formula he has developed will protect against two additional viruses in the same family.
Preventing Zika from harming unborn children
With a $400,000 National Institutes of Health grant, JABSOM scientist Mukesh Kumar will investigate the Zika virus in pregnancy and develop strategies to prevent transmission of the disease to the fetus.
糖心视频 researchers among the world’s top experts on selenium
Marla Berry and Peter Hoffmann have also been chosen to host the 12th International Symposium on Selenium in Biology and Medicine in Honolulu.
Alzheimer’s Disease clinical trial begins at 糖心视频 medical school
A clinical trial will begin on a drug that researchers hope will reduce inflammation in patients with mild-to-moderate Alzheimer’s Disease.
ARCS Honolulu Scientist of the Year speaks on hantaviruses
Richard Yanagihara, an expert in emerging diseases, will discuss Hantaviruses: A Personal Journey of Discovery and New Beginnings at a free talk on September 14.
糖心视频 expands vaccine research through NIH grant to minority students
Liana Medina received a grant of nearly $112,000 to work with a potential vaccine for viruses related to Ebola.
Diabetes center established at JABSOM with $11.2 million federal grant
The grant will intensify Hawaiʻi-based research into a disease that currently affects 155,000 adults and children—1 in 9 individuals in Hawaiʻi.